期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Role of Ni species in ZnO supported on Silicalite-1 for efficient propane dehydrogenation 被引量:1
1
作者 Bofeng Zhang mingxia song +5 位作者 Hongwang Liu Guozhu Li Sibao Liu Li Wang Xiangwen Zhang Guozhu Liu 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2022年第3期240-247,共8页
Propane dehydrogenation(PDH)is one of the most effective technologies to produce propene.Non-noble zinc-based catalysts have paid increasing attention because of low cost and nontoxic,compared with industrial Pt and C... Propane dehydrogenation(PDH)is one of the most effective technologies to produce propene.Non-noble zinc-based catalysts have paid increasing attention because of low cost and nontoxic,compared with industrial Pt and Cr-based catalysts.However,they often suffer from limited catalytic activity and poor stability.Here,we introduced moderate Ni into ZnO supported Silicalite-1 zeolite to increase catalytic activity and stability simultaneously.Zn^(2+) was the definite active site and NiZn alloy facilitated the sluggish H recombination into H_(2)via reverse spillover.Furthermore,the introduction of Ni increased Lewis acid strength caused by electron transfer from ZnO to NiZn alloy,contributing to improved stability.For resulted 0.5 NiZn/S-1,propene formation rate was 0.18 mol C_(3)H_(6)·(g Zn)^(-1)·h^(-1) at 550℃,which was above 1.5 times higher than that over Zn/S-1 without Ni.Under stability test,the deactivation of0.5 NiZn/S-1 was 0.019 h^(-1),which was only 1/10 of that over Zn/S-1. 展开更多
关键词 Propane dehydrogenation NiZn alloy Reverse hydrogen spillover Lewis acid ZEOLITE
下载PDF
胃肠间质瘤术前靶向治疗后的病理学评估与影像学评估的一致性分析
2
作者 宋明霞 张丽娟 +3 位作者 王忠丹 阮进秋 江凡 裴界磊 《中国肿瘤临床》 CAS 2024年第6期298-301,共4页
目的:探讨Choi标准及病理学效应对胃肠间质瘤(gastrointestinal stromal tumor, GIST)术前靶向治疗后疗效及预后的评估价值,并观察两者的一致性。方法:回顾性分析于昆明医科大学第三附属医院收治37例术前伊马替尼(imatinib,IM)靶向治疗G... 目的:探讨Choi标准及病理学效应对胃肠间质瘤(gastrointestinal stromal tumor, GIST)术前靶向治疗后疗效及预后的评估价值,并观察两者的一致性。方法:回顾性分析于昆明医科大学第三附属医院收治37例术前伊马替尼(imatinib,IM)靶向治疗GIST患者的临床病理资料,Kaplan-Meier法和Log-rank检验对Choi标准及病理学效应进行生存分析,Spearman等级相关及Kappa检验分析Choi标准与病理学效应的一致性。结果:37例患者术前中位治疗时间为10(2~36)个月。Choi标准评估无完全缓解(complete response,CR)病例,部分缓解(partial response,PR)26例,疾病稳定(stable disease,SD)5例,疾病进展(progressive disease,PD)6例;Choi标准疗效有效组(CR+PR)与无效组(SD+PD)之间总生存期的差异具有统计学意义(P<0.01)。病理学效应评估完全效应1例,高度效应11例,部分效应18例,零级效应7例;病理效应有效组(完全效应+高度效应+部分效应)与无效组(零级效应)之间总生存期的差异具有统计学意义(P<0.01)。Choi标准与病理学效应有相关性(r=0.592,P<0.01)及中度一致性(κappa=0.566)。结论:Choi标准与病理学效应有中等程度的相关性及一致性,两者均可作为胃肠间质瘤术前靶向治疗疗效评估及预后判断的参考指标,联合应用两者评估具有更高的临床应用价值。 展开更多
关键词 胃肠间质瘤 伊马替尼 影像学评估 病理学效应 预后
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部